Arabic Arabic English English French French German German
dark

FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment, Another Achievement in Administration’s Fight Against Pandemic

Today, FDA issued an EUA for convalescent plasma as part of ongoing efforts to fight COVID-19. Based on scientific evidence available, FDA concluded, this product may be effective in treating COVID-19. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Coronavirus (COVID-19) Update: Daily Roundup August 21, 2020

Next Post

Ortho Regenerative Technologies Closes Non-Brokered $2.5 Million Private Placement

Related Posts
Total
0
Share